FMC
43
4
CMI
71
2
NRG
80
3
STZ
77
3
LLY
64
-4
MCD
52
6
SWN
49
-4
PM
68
-2
GE
68
-2
DG
30
-2
FLS
71
2
DO
83
-3
EQIX
62
-2
GM
80
-2
CPB
49
2
CA
36
-4
LEG
20
2
PSX
47
-3
MHK
48
-10
EMR
65
-2
FMC
43
4
CMI
71
2
NRG
80
3
STZ
77
3
LLY
64
-4
MCD
52
6
SWN
49
-4
PM
68
-2
GE
68
-2
DG
30
-2
FLS
71
2
DO
83
-3
EQIX
62
-2
GM
80
-2
CPB
49
2
CA
36
-4
LEG
20
2
PSX
47
-3
MHK
48
-10
EMR
65
-2
Financhill
Back

ProShares Ultra Nasdaq Biotechnology Vs. Direxion Daily Phrmctcl&MdclBl3XShrsETF Industry Stock Comparison

Buy
60

BIB
ProShares Ultra Nasdaq Biotechnology

Last Price:
54.60
Seasonality Move:
12.47%
Sell
36

PILL
Direxion Daily Phrmctcl&MdclBl3XShrsETF

Last Price:
6.66
Seasonality Move:
14.52%
Buy
60
ProShares Ultra Nasdaq Biotechnology (BIB) is a Buy

Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?

  • The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $54.47. The Score for BIB is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • BIB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Direxion Daily Phrmctcl&MdclBl3XShrsETF (PILL) is a Sell

Is Direxion Daily Phrmctcl&MdclBl3XShrsETF a Buy, Sell or Hold?

  • The current Direxion Daily Phrmctcl&MdclBl3XShrsETF [PILL] share price is $6.68. The Score for PILL is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • PILL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BIB Stock Price Chart

What is ProShares Ultra Nasdaq Biotechnology's stock price today?

  • The ProShares Ultra Nasdaq Biotechnology share price today is $54.47
    The current trend is moderately bullish and BIB is experiencing selling pressure, which indicates risk of future bearish movement.

PILL Stock Price Chart

What is Direxion Daily Phrmctcl&MdclBl3XShrsETF's stock price today?

  • The Direxion Daily Phrmctcl&MdclBl3XShrsETF share price today is $6.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PILL is experiencing selling pressure, which indicates risk of future bearish movement.

BIB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.45 Buy
Relative Strength Index (14 RSI): 54.89 Buy
Chaikin Money Flow: -12036 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.4 - 54.52) Buy
Bollinger Bands (100): (52.83 - 59.25) Sell

PILL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 46.24 Sell
Chaikin Money Flow: -69490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.19 - 7.03) Buy
Bollinger Bands (100): (6.88 - 8.72) Sell

BIB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.73 Sell
20-day SMA: 51.64 Buy
50-day SMA: 54.38 Buy
200-day SMA: 52.06 Buy
8-day EMA: 54.29 Buy
20-day EMA: 53.25 Buy
50-day EMA: 53.84 Buy
200-day EMA: 53.61 Buy

PILL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.76 Sell
20-day SMA: 6.46 Buy
50-day SMA: 7.35 Sell
200-day SMA: 7.53 Sell
8-day EMA: 6.72 Sell
20-day EMA: 6.73 Sell
50-day EMA: 7.15 Sell
200-day EMA: 7.69 Sell

ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Direxion Daily Phrmctcl&MdclBl3XShrsETF Earnings Growth & PILL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

ProShares Ultra Nasdaq Biotechnology Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Direxion Daily Phrmctcl&MdclBl3XShrsETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):